Arcturus plans Phase II dosing of ARCT-2601 next quarter with top line data in 2H 2027 following 38-fold LUNAR 2.0 potency gain

Seeking Alpha · 市场快讯 · November 6, 2026 at 1:05 AM ET

Read the full report at the original publisher.